HSPB1 and non-small cell lung carcinoma: The expression of HSPB1 have distinct prognostic values in NSCLC patients, it can induce resistance to cisplatin in A549 cell through the regulation of Transforming growth factor β (TGF-β) (Huang et al., 2017; Huang et al., 2018).